Literature DB >> 19625398

Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways.

Samer Swedan1, Alla Musiyenko, Sailen Barik.   

Abstract

Viruses of the Paramyxoviridae family, such as the respiratory syncytial virus (RSV), suppress cellular innate immunity represented by type I interferon (IFN) for optimal growth in their hosts. The two unique nonstructural (NS) proteins, NS1 and NS2, of RSV suppress IFN synthesis, as well as IFN function, but their exact targets are still uncharacterized. Here, we investigate if either or both of the NS proteins affect the steady-state levels of key members of the IFN pathway. We found that both NS1 and NS2 decreased the levels of TRAF3, a strategic integrator of multiple IFN-inducing signals, although NS1 was more efficient. Only NS1 reduced IKKepsilon, a key protein kinase that specifically phosphorylates and activates IFN regulatory factor 3. Loss of the TRAF3 and IKKepsilon proteins appeared to involve a nonproteasomal mechanism. Interestingly, NS2 modestly increased IKKepsilon levels. In the IFN response pathway, NS2 decreased the levels of STAT2, the essential transcription factor for IFN-inducible antiviral genes. Preliminary mapping revealed that the C-terminal 10 residues of NS1 were essential for reducing IKKepsilon levels and the C-terminal 10 residues of NS2 were essential for increasing and reducing IKKepsilon and STAT2, respectively. In contrast, deletion of up to 20 residues of the C termini of NS1 and NS2 did not diminish their TRAF3-reducing activity. Coimmunoprecipitation studies revealed that NS1 and NS2 form a heterodimer. Clearly, the NS proteins of RSV, working individually and together, regulate key signaling molecules of both the IFN activation and response pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625398      PMCID: PMC2748017          DOI: 10.1128/JVI.00715-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production.

Authors:  J M Emeny; M J Morgan
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

Review 2.  The growing family of interferon regulatory factors.

Authors:  H Nguyen; J Hiscott; P M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  1997-12       Impact factor: 7.638

3.  The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.

Authors:  P L Atreya; M E Peeples; P L Collins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  Expression and characterisation of the NS1 and NS2 proteins of respiratory syncytial virus.

Authors:  J E Evans; P A Cane; C R Pringle
Journal:  Virus Res       Date:  1996-08       Impact factor: 3.303

6.  Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.

Authors:  S S Whitehead; A Bukreyev; M N Teng; C Y Firestone; M St Claire; W R Elkins; P L Collins; B R Murphy
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Respiratory syncytial virus. I. Concentration and purification of the infectious virus.

Authors:  O Ueba
Journal:  Acta Med Okayama       Date:  1978-08       Impact factor: 0.892

9.  Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.

Authors:  A Kibel; O Iliopoulos; J A DeCaprio; W G Kaelin
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

10.  RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3.

Authors:  M S Galinski; R M Troy; A K Banerjee
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

View more
  68 in total

1.  The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Authors:  Weining Wu; Kim C Tran; Michael N Teng; Kate J Heesom; David A Matthews; John N Barr; Julian A Hiscox
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Viral degradasome hijacks mitochondria to suppress innate immunity.

Authors:  Ramansu Goswami; Tanmay Majumdar; Jayeeta Dhar; Saurabh Chattopadhyay; Sudip K Bandyopadhyay; Valentina Verbovetskaya; Ganes C Sen; Sailen Barik
Journal:  Cell Res       Date:  2013-07-23       Impact factor: 25.617

3.  2'-5'-Oligoadenylate Synthetase-Like Protein Inhibits Respiratory Syncytial Virus Replication and Is Targeted by the Viral Nonstructural Protein 1.

Authors:  Jayeeta Dhar; Rolando A Cuevas; Ramansu Goswami; Jianzhong Zhu; Saumendra N Sarkar; Sailen Barik
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 4.  Animal models of respiratory syncytial virus infection and disease.

Authors:  Randy E Sacco; Russell K Durbin; Joan E Durbin
Journal:  Curr Opin Virol       Date:  2015-07-11       Impact factor: 7.090

Review 5.  Toll-like receptors: key players in antiviral immunity.

Authors:  Nicholas Arpaia; Gregory M Barton
Journal:  Curr Opin Virol       Date:  2011-10-28       Impact factor: 7.090

6.  Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.

Authors:  Jingjing Pei; Nicole D Wagner; Angela J Zou; Srirupa Chatterjee; Dominika Borek; Aidan R Cole; Preston J Kim; Christopher F Basler; Zbyszek Otwinowski; Michael L Gross; Gaya K Amarasinghe; Daisy W Leung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

7.  Nonstructural protein-1 of respiratory syncytial virus regulates HOX gene expression through interacting with histone.

Authors:  Yu-Rong Tan; Dan Peng; Cui-Mei Chen; Xiao-Qun Qin
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

Review 8.  Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes.

Authors:  Christopher C Stobart; Martin L Moore
Journal:  Expert Rev Vaccines       Date:  2015-10-05       Impact factor: 5.217

9.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

10.  Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Authors:  Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.